Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Medtronic ( (MDT) ) just unveiled an update.
On October 16, 2025, Medtronic held its Annual General Meeting where shareholders elected twelve directors to serve until the 2026 meeting, ratified PricewaterhouseCoopers LLP as the independent auditor for fiscal year 2026, and approved executive compensation. Additionally, the meeting saw the renewal of the Board’s authority to issue shares and opt out of pre-emption rights, authorization for overseas market purchases of shares, and amendments to the Articles of Association to facilitate reserve capitalization and update advance notice provisions. These decisions are poised to impact Medtronic’s governance and financial strategies, potentially enhancing shareholder value and operational flexibility.
The most recent analyst rating on (MDT) stock is a Hold with a $103.00 price target. To see the full list of analyst forecasts on Medtronic stock, see the MDT Stock Forecast page.
Spark’s Take on MDT Stock
According to Spark, TipRanks’ AI Analyst, MDT is a Outperform.
Medtronic’s overall stock score of 80 reflects strong financial performance and positive earnings call sentiment, supported by strategic corporate events. While the valuation is on the higher side, the company’s robust growth prospects and stable technical indicators contribute to a favorable outlook.
To see Spark’s full report on MDT stock, click here.
More about Medtronic
Average Trading Volume: 7,059,364
Technical Sentiment Signal: Buy
Current Market Cap: $123B
See more data about MDT stock on TipRanks’ Stock Analysis page.